Desh Rakshak Aushdhalaya Peer Comparison

Desh Rakshak Aushdhalaya Ltd. is significantly underperforming compared to its peers in the Pharmaceuticals & Drugs sector, exhibiting no revenue growth, profitability, or efficiency metrics. The company is surrounded by peers demonstrating strong growth, profitability, and low debt levels, indicating a challenging outlook unless substantial operational improvements are made.

• • Desh Rakshak Aushdhalaya Ltd. has zero revenue growth and profitability metrics, significantly lagging behind peers.
• • Top performers like Sun Pharmaceutical and Dr. Reddy's demonstrate robust growth and high profitability with low debt levels.
• • The company's current valuation metrics suggest it is overvalued given its lack of financial performance.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth (YoY 8.42%) and EPS (45.55) with strong profitability metrics (ROE 16.13%).
• • Dr. Reddy's Laboratories Ltd.: Strong profitability (ROE 21.76%) and growth (YoY revenue growth 16.54%) with attractive valuation metrics.
• • Cipla Ltd.: Good balance of growth (YoY revenue growth 13.28%) and low valuation (PE 23.73).